Clinical Trial Update: Study of MK-6552 in Participants With Narcolepsy Type 1 (MK-6552-004) [Phase 1]

View source ↗

Summary

A Phase 1 study of MK-6552 in participants with narcolepsy has been terminated, with results posted on 2026-04-14.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Narcolepsy

Drugs mentioned

• MK-6552

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Narcolepsy | Phase 1 | Status: TERMINATED | Results posted: 2026-04-14